Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $25000.0.

  • Zenas BioPharma's Exchange Rate Effect rose 14807.69% to $25000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$122000.0, marking a year-over-year decrease of 7183.1%. This contributed to the annual value of $157000.0 for FY2024, which is 10128.21% up from last year.
  • According to the latest figures from Q3 2025, Zenas BioPharma's Exchange Rate Effect is $25000.0, which was up 14807.69% from -$236000.0 recorded in Q2 2025.
  • Zenas BioPharma's 5-year Exchange Rate Effect high stood at $141000.0 for Q4 2024, and its period low was -$236000.0 during Q2 2025.
  • For the 3-year period, Zenas BioPharma's Exchange Rate Effect averaged around -$24125.0, with its median value being -$13500.0 (2024).
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first surged by 26206.9% in 2024, then tumbled by 83750.0% in 2025.
  • Quarter analysis of 3 years shows Zenas BioPharma's Exchange Rate Effect stood at -$87000.0 in 2023, then skyrocketed by 262.07% to $141000.0 in 2024, then plummeted by 82.27% to $25000.0 in 2025.
  • Its Exchange Rate Effect stands at $25000.0 for Q3 2025, versus -$236000.0 for Q2 2025 and -$52000.0 for Q1 2025.